SCHEMBL14878886

SCHEMBL14878886

Ic1cc2[nH]ccc2cc1-c1cccnc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 2/20 0.50
▸ GSK3B P49841 1/20 0.48
▸ DYRK1A Q13627 1/20 0.48
▸ NUDT1 P36639 1/20 0.47
▸ CYP11B1 P15538 2/20 0.46
▸ CYP19A1 P11511 1/20 0.44
▸ ATR Q13535 2/20 0.43
▸ MAPK1 P28482 2/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ TLR8 Q9NR97 1/20 0.40
▸ TLR7 Q9NYK1 1/20 0.40
▸ FGFR1 P11362 1/20 0.40
▸ GRM1 Q13255 1/20 0.40
▸ GHSR Q92847 1/20 0.40
▸ GPR84 Q9NQS5 1/20 0.40
▸ QPCT Q16769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14823134 0.84 CYP11B1 (0.53) TDO2GSK3BDYRK1ANUDT1CYP11B1
SCHEMBL8957505 0.80 NUDT1 (0.43) TDO2GSK3BDYRK1ANUDT1CYP11B1
SCHEMBL9001704 0.80 CYP11B1 (0.47) TDO2GSK3BDYRK1ANUDT1CYP11B1
SCHEMBL6657347 0.76 NPC1 (0.64) CYP11B1CYP19A1ATRCYP11B2ALDH1A1
SCHEMBL7497614 0.76 FGFR1 (0.62) CYP11B1CYP19A1ATRCYP11B2ALDH1A1
SCHEMBL5831050 0.70 PIK3CD (0.68) TDO2GSK3BDYRK1ANUDT1CYP11B1
SCHEMBL31735555 0.69 NUDT1 (0.52) TDO2GSK3BDYRK1ANUDT1CYP11B1
SCHEMBL7493615 0.68 HASPIN (0.51) TDO2DYRK1ACYP11B1CYP11B2TLR8
SCHEMBL16241832 0.68 HASPIN (0.51) TDO2DYRK1ACYP11B1CYP11B2TLR8
SCHEMBL16694670 0.68 CYP2A6 (0.70) TDO2DYRK1ACYP11B1CYP19A1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231671-B1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2013-04-24 — — EP disclosed
Send feedback